Log in

Relevant bibliographies by topics / Mitochondrial diseases / Books

Books on the topic 'Mitochondrial diseases'

To see the other types of publications on this topic, follow the link: Mitochondrial diseases.

Author: Grafiati

Published: 4 June 2021

Last updated: 9 March 2023

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 books for your research on the topic 'Mitochondrial diseases.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse books on a wide variety of disciplines and organise your bibliography correctly.

1

James, Holt Ian, ed. Genetics of mitochondrial diseases. Oxford: Oxford University Press, 2003.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

2

Navas, Placido, and Leonardo Salviati, eds. Mitochondrial Diseases. Cham: Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-70147-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Lestienne, Patrick, ed. Mitochondrial Diseases. Berlin, Heidelberg: Springer Berlin Heidelberg, 1999. http://dx.doi.org/10.1007/978-3-642-59884-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

service), ScienceDirect (Online, ed. Mitochondrial function: Mitochondrial protein kinases, protein phosphatases and mitochondrial diseases. San Diego, Calif: Academic Press/Elsevier, 2009.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

5

N, Gellerich Frank, Zierz S, and Colloquium on Mitochondria and Myopathies (1st : 1995 : Halle an der Saale, Germany), eds. Detection of mitochondrial diseases. Dordrecht: Kluwer Academic, 1997.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

6

Sun, Hongzhi, and Xiangdong Wang, eds. Mitochondrial DNA and Diseases. Singapore: Springer Singapore, 2017. http://dx.doi.org/10.1007/978-981-10-6674-0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Gellerich, Frank Norbert, and Stephan Zierz, eds. Detection of Mitochondrial Diseases. Boston, MA: Springer US, 1997. http://dx.doi.org/10.1007/978-1-4615-6111-8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Anna, Gvozdjáková, ed. Mitochondrial medicine: Mitochondrial metabolism, diseases, diagnosis and therapy. Dordrecht: Springer, 2008.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

9

V, Schapira Anthony H., and DiMauro S, eds. Mitochondrial disorders in neurology. Oxford: Butterworth-Heinemann, 1994.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

10

S, DiMauro, Hirano Michio, and Schon Eric A, eds. Mitochondrial medicine. Abingdon [U.K.]: Informa Healthcare, 2006.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

11

Mitochondrial medicine. New York: Humana Press, 2015.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

12

Mitochondrial dysfunction and oxidativedamage in neurodegenerative diseases. New York: Springer, 1995.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

13

M, Smeitink Jan A., Sengers Rob C. A, and Trijbels J. M. Frans, eds. Oxidative phosphorylation in health and disease. Georgetown, Tex., U.S.A: Landes Bioscience/Eurekah.com, 2004.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

14

Beal, M. Flint. Mitochondrial dysfunction and oxidative damage in neurodegenerative diseases. Austin: R.G. Landes Co., 1995.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

15

C, St John Justin, ed. The mitochondrion in the germline and early development. San Diego, Calif: Academic Press, 2007.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

16

Advances in mitochondrial medicine. Dordrecht: Springer Verlag, 2012.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

17

Mitochondrial signaling in health and disease. Boca Raton: Taylor & Francis/CRC Press, 2012.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

18

Reeve, Amy Katherine. Mitochondrial Dysfunction in Neurodegenerative Disorders. London: Springer-Verlag London Limited, 2012.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

19

Hidaka, Takuya. Sequence-Specific DNA Binders for the Therapy of Mitochondrial Diseases. Singapore: Springer Singapore, 2022. http://dx.doi.org/10.1007/978-981-16-8436-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

R, Sanberg Paul, Nishino Hitoo, and Borlongan Cesario V, eds. Mitochondrial inhibitors and neurodegenerative disorders. Totowa, N.J: Humana Press, 2000.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

21

Marín-García, José. Mitochondria and their role in cardiovascular disease. New York: Springer, 2013.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

22

Mitochondrial Diseases: Models and Methods. Springer, 2011.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

23

Lestienne, Patrick. Mitochondrial Diseases: Models and Methods. Springer London, Limited, 2012.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

24

Lestienne, Patrick. Mitochondrial Diseases: Models and Methods. Springer, 2011.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

25

Lestienne, Patrick, ed. Mitochondrial Diseases: Models and Methods. SPRINGER-VERLAG, 1999.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

26

Gorman, Gráinne S., and Patrick F. Chinnery. Mitochondrial diseases. Oxford University Press, 2015. http://dx.doi.org/10.1093/med/9780199658602.003.0011.

Full text

Abstract:

This chapter critiques ten seminal papers that epitomize the advent and evolution of mitochondrial medicine from the latter half of the last century up until today. These important bodies of work span the pre-molecular and molecular eras, from when diagnostic yield was based on meticulous clinical and biochemical characterization of patients, up until now, with targeted next-generation sequencing revolutionizing our diagnostic approach. The first clinical description of a mitochondrial disorder is reviewed and the subsequent landmark papers that define current clinical and molecular understanding of human diseases caused by inherited disorders of mitochondrial dysfunction are chronicled. The chapter also charts the shift in emphasis from diagnosis to the development of treatments and novel approaches for disease prevention.

APA, Harvard, Vancouver, ISO, and other styles

27

Taskin, Eylem, Celal Guven, and Yusuf Sevgiler, eds. Mitochondrial Diseases. InTech, 2018. http://dx.doi.org/10.5772/67963.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

Wiley. Mitochondrial Diseases. Wiley & Sons, Incorporated, John, 2013.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

29

Taskin, Eylem, Celal Guven, and Yusuf Sevgiler. Mitochondrial Diseases. IntechOpen, 2018.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

30

Wiley. Mitochondrial Diseases. Wiley & Sons, Incorporated, John, 2013.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

31

Hirano, Michio, Rita Horvath, and Patrick Francis Chinnery. Mitochondrial Diseases. Elsevier, 2022.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

32

Horvath, Rita, MIchi Hirano, and Patrick Francis Chinnery. Mitochondrial Diseases. Elsevier, 2022.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

33

Berdanier, Carolyn D. Mitochondria in Health and Disease. Taylor & Francis Group, 2005.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

34

Mitochondria in health and disease. Boca Raton, Fla: Dekker, 2005.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

35

Berdanier, Carolyn D. Mitochondria in Health and Disease. Taylor & Francis Group, 2005.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

36

Knott, Andrew B., and Ella Bossy-Wetzel. Mitochondrial Changes and Bioenergetics in Neurodegenerative Diseases. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780190233563.003.0012.

Full text

Abstract:

Mitochondria are dynamic organelles that are of critical importance for cellular survival and health. Because mitochondria play central roles in energy production and synaptic maintenance, neurons are believed to be particularly vulnerable to mitochondrial dysfunction. The discovery that genetic mutations in genes coding for mitochondrial proteins cause neurodegenerative conditions further hinted at the likelihood that mitochondrial dysfunction is a key pathway of neurodegeneration. Indeed, a wealth of research has identified mitochondrial dysfunction as an early and shared event of all common neurodegenerative diseases, both genetic and sporadic in origin. Specific types of mitochondrial dysfunction that have been observed in most neurodegenerative diseases include bioenergetic failure, increased oxidative stress, mitochondrial DNA mutations, defective calcium handling, impaired mitochondrial dynamics, defective mitophagy, and decreased mitochondrial biogenesis. The search for drugs that successfully target these pathways of mitochondrial dysfunction in neurodegeneration is ongoing.

APA, Harvard, Vancouver, ISO, and other styles

37

Wang, Xiangdong, and Hongzhi Sun. Mitochondrial DNA and Diseases. Springer, 2018.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

38

Mitochondrial Diseases [Working Title]. IntechOpen, 2021. http://dx.doi.org/10.5772/intechopen.91518.

Full text

APA, Harvard, Vancouver, ISO, and other styles

39

Detection of Mitochondrial Diseases. Springer, 2011.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

40

Wang, Xiangdong, and Hongzhi Sun. Mitochondrial DNA and Diseases. Springer, 2017.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

41

Mitochondrial DNA and Diseases. Springer, 2017.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

42

Gellerich, F. N. Detection of Mitochondrial Diseases. Springer, 2012.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

43

Gellerich, F. N., and S. Zierz. Detection of Mitochondrial Diseases. Springer London, Limited, 2012.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

44

Mitochondrial function and dysfunction. Amsterdam: Academic Press, 2002.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

45

Gvozdjáková, Anna. Mitochondrial Medicine: Mitochondrial Metabolism, Diseases, Diagnosis and Therapy. Springer, 2014.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

46

(Contributor), S. Di Mauro, ed. Mitochondrial Disorders. Springer, 2002.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

47

Mitochondrial Function, Part B: Mitochondrial Protein Kinases, Protein Phosphatases and Mitochondrial Diseases. Elsevier, 2009. http://dx.doi.org/10.1016/s0076-6879(09)x0026-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

Weissman, Jacqueline, and Lisa Emrick. Diseases of Mitochondrial Energy Metabolism. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199937837.003.0061.

Full text

Abstract:

Mitochondrial disorders are a group of inherited diseases of energy metabolism caused by impairment of mitochondrial function-primarily disorders of the oxidative phosphorylation system but also the more recently described disorders of mitochondrial transport and fission. This review will focus on primary disorders of mitochondrial oxidative phosphorylation. The neurologic system is one of the most profoundly affected by mitochondrial dysfunction and the effects can be varied and widespread. This has led to these diseases being commonly called mitochondrial encephalomyopathies. The heterogeneity of clinical presentation, laboratory findings, neuroimaging findings, pathologic findings, and genetic findings in these diseases make diagnosis extremely difficult. Treatment for mitochondrial disorders is currently lacking a solid evidence base but this is a rapidly expanding area of research.

APA, Harvard, Vancouver, ISO, and other styles

49

Hall, Andrew, and Shamima Rahman. Mitochondrial diseases and the kidney. Edited by Neil Turner. Oxford University Press, 2015. http://dx.doi.org/10.1093/med/9780199592548.003.0340.

Full text

Abstract:

Mitochondrial disease can affect any organ in the body including the kidney. As increasing numbers of patients with mitochondrial disease are either surviving beyond childhood or being diagnosed in adulthood, it is important for all nephrologists to have some understanding of the common renal complications that can occur in these individuals. Mitochondrial proteins are encoded by either mitochondrial or nuclear DNA (mtDNA and nDNA, respectively); therefore, disease causing mutations may be inherited maternally (mtDNA) or autosomally (nDNA), or can arise spontaneously. The commonest renal phenotype in mitochondrial disease is proximal tubulopathy (Fanconi syndrome in the severest cases); however, as all regions of the nephron can be affected, from the glomerulus to the collecting duct, patients may also present with proteinuria, decreased glomerular filtration rate, nephrotic syndrome, water and electrolyte disorders, and renal tubular acidosis. Understanding of the relationship between underlying genotype and clinical phenotype remains incomplete in mitochondrial disease. Proximal tubulopathy typically occurs in children with severe multisystem disease due to mtDNA deletion or mutations in nDNA affecting mitochondrial function. In contrast, glomerular disease (focal segmental glomerulosclerosis) has been reported more commonly in adults, mainly in association with the m.3243A<G point mutation. Co-enzyme Q10 (CoQ10) deficiency has been particularly associated with podocyte dysfunction and nephrotic syndrome in children. Underlying mitochondrial disease should be considered as a potential cause of unexplained renal dysfunction; clinical clues include lack of response to conventional therapy, abnormal mitochondrial morphology on kidney biopsy, involvement of other organs (e.g. diabetes, cardiomyopathy, and deafness) and a maternal family history, although none of these features are specific. The diagnostic approach involves acquiring tissue (typically skeletal muscle) for histological analysis, mtDNA screening and oxidative phosphorylation (OXPHOS) complex function tests. A number of nDNA mutations causing mitochondrial disease have now been identified and can also be screened for if clinically indicated. Management of mitochondrial disease requires a multidisciplinary approach, and treatment is largely supportive as there are currently very few evidence-based interventions. Electrolyte deficiencies should be corrected in patients with urinary wasting due to tubulopathy, and CoQ10 supplementation may be of benefit in individuals with CoQ10 deficiency. Nephrotic syndrome in mitochondrial disease is not typically responsive to steroid therapy. Transplantation has been performed in patients with end-stage kidney disease; however, immunosuppressive agents such as steroids and tacrolimus should be used with care given the high incidence of diabetes in mitochondrial disease.

APA, Harvard, Vancouver, ISO, and other styles

50

Sciarretta, Sebastiano, Richard N. Kitsis, and Junichi Sadoshima, eds. Mitochondrial Dysfunction and Cardiovascular Diseases. Frontiers Media SA, 2021. http://dx.doi.org/10.3389/978-2-88966-556-3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!